bibliographicCitation |
Juhnke M, Heumann A, Chirico V, Höflmayer D, Menz A, Hinsch A, Hube‐Magg C, Kluth M, Lang DS, Möller‐Koop C, Sauter G, Simon R, Beyer B, Pompe R, Thederan I, Schlomm T, Luebke AM. Apurinic/apyrimidinic endonuclease 1 (APE1/Ref‐1) overexpression is an independent prognostic marker in prostate cancer without TMPRSS2:ERG fusion. Molecular Carcinogenesis. 2017 May 22;56(9):2135–45. doi: 10.1002/mc.22670. |